| POLAR CAPITAL BIOTECHNOLOGY S USD DIS | RVI BIOTECNOLOGÍA | 56,37% | 109,46% | 101,63% | 409,01% |
| GOLDMAN SACHS GLOBAL FUTURE TECHNOLOGY LEADERS EQUITY PORTFOLIO R USD DIS | RVI TECNOLOGÍA | 56,36% | 110,56% | 43,99% | · |
| GOLDMAN SACHS GLOBAL FUTURE TECHNOLOGY LEADERS EQUITY PORTFOLIO R USD CAP | RVI TECNOLOGÍA | 56,32% | 110,32% | 44,05% | · |
| MULTIUNITS LUX - AMUNDI MSCI EMERGING EX CHINA UCITS ETF ACC USD | RVI EMERGENTES | 56,21% | 91,02% | 85,15% | · |
| ABRDN SICAV I-FUTURE MINERALS FUND S ACC EUR HEDGED | RVI MATERIAS PRIMAS | 56,18% | 63,78% | 56,08% | 114,16% |
| NEUBERGER BERMAN NEXT GENERATION CONNECTIVITY EUR A ACC | RVI TECNOLOGÍA | 56,07% | 168,51% | 97,53% | · |
| NEUBERGER BERMAN NEXT GENERATION CONNECTIVITY GBP A ACC (HEDGED) | RVI TECNOLOGÍA | 56,05% | 182,85% | 84,68% | · |
| INVESCO EMERGING MARKETS EX-CHINA EQUITY Z CAP EUR (HEDGED) | RVI ASIA PACÍFICO | 56,04% | · | · | · |
| CANDRIAM EQUITIES L BIOTECHNOLOGY R-H CAP EUR | RVI BIOTECNOLOGÍA | 56,03% | 86,61% | 65,54% | · |
| VANGUARD FTSE DEVELOPED ASIA PACIFIC EX JAPAN UCITS ETF USD DIST | RVI ASIA EX-JAPÓN | 56,01% | 76,62% | 49,49% | 96,58% |
